Back to User profile » Dr Kashif Asghar
Papers published by Dr Kashif Asghar:
Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort
Farooq A, Amin A, Bashir S, Fatima M, Hassan M, Sheikh AZ, Tahseen M, Sheikh UN, Asghar K
OncoTargets and Therapy 2025, 18:367-377
Published Date: 17 March 2025
PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients
Asghar K, Bashir S, Ali Rana I, Abu Bakar M, Farooq A, Hassan M, Asif Z, Afzal M, Masood I, Ishaq M, Tahseen M, Bilal S, Mehmood S, Kanwal N, Ud Din I, Loya A
Journal of Hepatocellular Carcinoma 2023, 10:921-934
Published Date: 17 June 2023
Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan
Asghar K, Loya A, Ali Rana I, Tahseen M, Ishaq M, Farooq A, Abu Bakar M, Masood I
Cancer Management and Research 2019, 11:475-481
Published Date: 3 January 2019
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
Zulfiqar B, Mahroo A, Nasir K, Farooq RK, Jalal N, Rashid MU, Asghar K
OncoTargets and Therapy 2017, 10:463-476
Published Date: 21 January 2017